Prevalence of diagnosed type 2 diabetes mellitus in the French general population: The INSTANT study

Diabetes and Metabolism

Volumn 35, Issue 1, 2009, Pages 25-31

  Bringer, J ^a   Fontaine, P ^b   Detournay, B ^c   Nachit Ouinekh, F ^d   Brami, G ^d   Eschwege, E ^e  

^a LAPEYRONIE HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c CEMKA EVAL   (France)

^d GLAXOSMITHKLINE   (France)

^e INSERM   (France)

Author keywords

Cross sectional study; Epidemiology; Prevalence; Treatment; Type 2 diabetes mellitus

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLITAZONE DERIVATIVE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ANAMNESIS; ANGINA PECTORIS; ARTERY DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FRANCE; HEALTH SURVEY; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR;

EID: 60649121516     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2008.06.004     Document Type: Article

References (19)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
2. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
3. Ricordeau P., Weill A., Vallier N., Bourrel R., Schwartz D., Guilhot J., et al. The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?. Diabetes Metab 29 (2003) 497-504
4. Kusnik-Joinville O.A.W., Salanave B., Ricordeau P., and Allemand H. Diabète traité : quelles évolutions entre 2000 et 2005 ?. Prat Organ Soins 38 (2007) 1-12
5. Charles MA, Basdevant A. ObEpi 2006. Enquête nationale sur le surpoids et l'obésité. Enquête Inserm, TNS SOFRES, Roche 2007.
6. Fagot-Campagna A., Simon D., Varroud-Vial M., Ihaddadène K., Vallier N., Scaturro S., et al. Caractéristiques des personnes diabétiques traitées et adéquation du suivi médical du diabète aux recommandations officielles. Entred 2001. Bull Epidemiol Hebd 49-50 (2003) 238-239
7. Hillier T.A., Fosse S., Balkau B., Simon D., Eschwege E., and Fagot-Campagna A. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study. J Cardiometab Syn 1 (2006 Fall) 318-325
8. Varroud-Vial M., Guerci B., Attali C., Simon D., Detournay B., Halimi S., et al. Prise en charge du diabète en France : des progrès certains. Res Diabete (2007) 4-9
9. Cogneau J., Balkau B., Weill A., Liard F., and Simon D. Assessment of diabetes screening by general practitioners in France: the EPIDIA Study. Diabet Med 23 (2006) 803-807
10. Welborn T.A., Reid C.M., and Marriott G. Australian Diabetes Screening Study: impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Metab Clin Expl 46 (1997) 35-39
11. Eschwège E. Epidemiology of type II diabetes, diagnosis, prevalence, risk factors, complications. Arch Mal Coeur Vaiss 93 (2000) 13-17
12. Codiab-Inserm-Zeneca Pharma Study Group, Delcourt C., Vauzelle-Kervroedan F., Cathelineau G., and Papoz L. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. J Diabet Complications 12 (1998) 88-95
13. Detournay B., Cros S., Charbonnel B., Grimaldi A., Liard F., Cogneau J., et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab 26 (2000) 363-369
14. Roberts S. Turning the corner: improving diabetes care (2006), Department of Health, London
15. Calza S., Decarli A., and Ferraroni M. Obesity and prevalence of chronic diseases in the 1999-2000 Italian National Health Survey. BMC Public Health 8 (2008) 140
16. Bays H.E., Bazata D.D., Clark N.G., Gavin III J.R., Green A.J., Lewis S.J., et al. Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes). BMC Public Health 7 (2007) 277
17. Gikas A., Sotiropoulos A., Panagiotakos D., Peppas T., Skliros E., and Pappas S. Prevalence, and associated risk factors, of self-reported diabetes mellitus in a sample of adult urban population in Greece: MEDICAL Exit Poll Research in Salamis (MEDICAL EXPRESS 2002). BMC Public Health 14 4 (2004) 2
18. Suvisaari J., Perala J., Saarni S.I., Harkanen T., Pirkola S., Joukamaa M., et al. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Eur Arch Psychiatry Clin Neurosci (2007)
19. Fleming D.M., Schellevis F.G., and Van Casteren V. The prevalence of known diabetes in eight European countries. Eur J Public Health 14 (2004) 10-14